Hydrocortisone Butyrate Patent Expiration
Hydrocortisone Butyrate was first introduced by Bausch Health Us Llc
Hydrocortisone Butyrate Patents
Given below is the list of patents protecting Hydrocortisone Butyrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Locoid | US7378405 | Stabilized steroid composition and method for its preparation | Dec 19, 2026 | Bausch |
| Locoid | US7981877 | Stabilized steroid composition and method for its preparation |
Jan 23, 2025
(Expired) | Bausch |
| Locoid Lipocream | US5635497 | Topical application compositions |
Jun 03, 2014
(Expired) | Precision Dermat |
Hydrocortisone Butyrate's Family Patents
Explore Our Curated Drug Screens
Hydrocortisone Butyrate Generic API Manufacturers
Several generic applications have been filed for Hydrocortisone Butyrate. The first generic version for Hydrocortisone Butyrate was by Taro Pharmaceutical Industries Ltd and was approved on Jan 14, 2004. And the latest generic version is by Lupin Ltd and was approved on Aug 17, 2018.
Given below is the list of companies who have filed for Hydrocortisone Butyrate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB2 | Dec 8, 2017 |
2. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB2 | Sep 27, 2013 |
3. LUPIN LTD
Lupin Ltd has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1%
(reference standard) | lotion | Prescription | TOPICAL | AB | Aug 17, 2018 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | ointment | Prescription | TOPICAL | AB | Dec 27, 2004 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||
5. TARO PHARM INDS
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB1 | Aug 3, 2005 |
6. THE J MOLNER
The J Molner Co Ou has filed for 1 generic for Hydrocortisone Butyrate. Given below are the details of the strengths of this generic introduced by The J Molner.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Prescription | TOPICAL | AB | Nov 21, 2017 |